vs
Northfield Bancorp, Inc.（NFBK）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Northfield Bancorp, Inc.的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.2倍（$41.3M vs $35.5M），RECURSION PHARMACEUTICALS, INC.净利率更高（-304.2% vs -1545.5%，领先1241.3%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 12.7%），Northfield Bancorp, Inc.自由现金流更多（$52.5M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 15.0%）
诺斯菲尔德银行控股公司是总部位于美国的区域性银行机构，主要服务美国东北部市场，面向个人消费者、中小企业及本地社区客户提供储蓄存款、住房贷款、商业信贷、财富管理等多元银行服务。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
NFBK vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $41.3M | $35.5M |
| 净利润 | $-27.4M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | -1263.3% | -304.8% |
| 净利率 | -1545.5% | -304.2% |
| 营收同比 | 12.7% | 681.7% |
| 净利润同比 | -343.6% | 39.6% |
| 每股收益（稀释后） | $-0.68 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $41.3M | $35.5M | ||
| Q3 25 | $39.2M | $5.2M | ||
| Q2 25 | $38.9M | $19.2M | ||
| Q1 25 | $34.8M | $14.7M | ||
| Q4 24 | $36.7M | $4.5M | ||
| Q3 24 | $31.8M | $26.1M | ||
| Q2 24 | $31.5M | $14.4M | ||
| Q1 24 | $31.3M | $13.8M |
| Q4 25 | $-27.4M | $-108.1M | ||
| Q3 25 | $10.8M | $-162.3M | ||
| Q2 25 | $9.6M | $-171.9M | ||
| Q1 25 | $7.9M | $-202.5M | ||
| Q4 24 | $11.3M | $-178.9M | ||
| Q3 24 | $6.5M | $-95.8M | ||
| Q2 24 | $6.0M | $-97.5M | ||
| Q1 24 | $6.2M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | -1263.3% | -304.8% | ||
| Q3 25 | 37.7% | -3327.6% | ||
| Q2 25 | 35.6% | -916.8% | ||
| Q1 25 | 31.0% | -1297.9% | ||
| Q4 24 | 38.0% | -4042.4% | ||
| Q3 24 | 27.9% | -377.1% | ||
| Q2 24 | 29.1% | -697.4% | ||
| Q1 24 | 27.2% | -698.4% |
| Q4 25 | -1545.5% | -304.2% | ||
| Q3 25 | 27.4% | -3135.3% | ||
| Q2 25 | 24.6% | -894.2% | ||
| Q1 25 | 22.6% | -1373.3% | ||
| Q4 24 | 30.7% | -3935.5% | ||
| Q3 24 | 20.5% | -367.5% | ||
| Q2 24 | 18.9% | -676.6% | ||
| Q1 24 | 19.9% | -662.4% |
| Q4 25 | $-0.68 | $-0.17 | ||
| Q3 25 | $0.27 | $-0.36 | ||
| Q2 25 | $0.24 | $-0.41 | ||
| Q1 25 | $0.19 | $-0.50 | ||
| Q4 24 | $0.27 | $-0.56 | ||
| Q3 24 | $0.16 | $-0.34 | ||
| Q2 24 | $0.14 | $-0.40 | ||
| Q1 24 | $0.15 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $164.0M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $690.1M | $1.1B |
| 总资产 | $5.8B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $164.0M | $743.3M | ||
| Q3 25 | $131.7M | $659.8M | ||
| Q2 25 | $97.6M | $525.1M | ||
| Q1 25 | $101.7M | $500.5M | ||
| Q4 24 | $167.7M | $594.4M | ||
| Q3 24 | $232.9M | $427.6M | ||
| Q2 24 | $153.5M | $474.3M | ||
| Q1 24 | $238.8M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | $666.4M | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $690.1M | $1.1B | ||
| Q3 25 | $719.6M | $1.0B | ||
| Q2 25 | $710.3M | $919.1M | ||
| Q1 25 | $711.1M | $933.9M | ||
| Q4 24 | $704.7M | $1.0B | ||
| Q3 24 | $699.6M | $524.6M | ||
| Q2 24 | $693.0M | $584.4M | ||
| Q1 24 | $698.4M | $401.2M |
| Q4 25 | $5.8B | $1.5B | ||
| Q3 25 | $5.7B | $1.4B | ||
| Q2 25 | $5.7B | $1.3B | ||
| Q1 25 | $5.7B | $1.3B | ||
| Q4 24 | $5.7B | $1.4B | ||
| Q3 24 | $5.7B | $726.5M | ||
| Q2 24 | $5.7B | $775.9M | ||
| Q1 24 | $5.9B | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | 0.95× | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $53.7M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $52.5M | $-47.3M |
| 自由现金流率自由现金流/营收 | 127.1% | -133.1% |
| 资本支出强度资本支出/营收 | 2.8% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $89.2M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $53.7M | $-46.1M | ||
| Q3 25 | $13.9M | $-117.4M | ||
| Q2 25 | $14.1M | $-76.4M | ||
| Q1 25 | $9.4M | $-132.0M | ||
| Q4 24 | $31.1M | $-115.4M | ||
| Q3 24 | $14.0M | $-59.2M | ||
| Q2 24 | $6.9M | $-82.2M | ||
| Q1 24 | $4.2M | $-102.3M |
| Q4 25 | $52.5M | $-47.3M | ||
| Q3 25 | $13.6M | $-117.6M | ||
| Q2 25 | $13.9M | $-79.6M | ||
| Q1 25 | $9.2M | $-133.8M | ||
| Q4 24 | $30.0M | $-116.7M | ||
| Q3 24 | $13.7M | $-63.8M | ||
| Q2 24 | $6.7M | $-83.4M | ||
| Q1 24 | $3.8M | $-109.0M |
| Q4 25 | 127.1% | -133.1% | ||
| Q3 25 | 34.6% | -2272.5% | ||
| Q2 25 | 35.7% | -413.9% | ||
| Q1 25 | 26.3% | -907.4% | ||
| Q4 24 | 81.6% | -2567.7% | ||
| Q3 24 | 43.2% | -244.6% | ||
| Q2 24 | 21.1% | -578.5% | ||
| Q1 24 | 12.1% | -789.9% |
| Q4 25 | 2.8% | 3.5% | ||
| Q3 25 | 0.8% | 4.7% | ||
| Q2 25 | 0.6% | 16.4% | ||
| Q1 25 | 0.7% | 12.4% | ||
| Q4 24 | 3.1% | 28.6% | ||
| Q3 24 | 0.7% | 17.5% | ||
| Q2 24 | 0.8% | 8.2% | ||
| Q1 24 | 1.4% | 48.2% |
| Q4 25 | — | — | ||
| Q3 25 | 1.29× | — | ||
| Q2 25 | 1.48× | — | ||
| Q1 25 | 1.20× | — | ||
| Q4 24 | 2.76× | — | ||
| Q3 24 | 2.14× | — | ||
| Q2 24 | 1.16× | — | ||
| Q1 24 | 0.68× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
